Skip to search formSkip to main contentSkip to account menu

N-cyclopropyl adenosine-5'-carboxamide

Known as: 1-(6-amino-9H-purin-9-yl)-N-cyclopropyl-1-deoxy-beta-D-ribofuranuronamide, 5'-(N-cyclopropyl)carboxamidoadenosine, CPCA 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2008
2008
A novel approach was developed to rationally interface structure- and ligand-based drug design through the rescoring of docking… 
2008
2008
In multivariate statistic process control (MSPC), the projection methods, in particular, the principal component analysis (PCA… 
2005
2005
An evaluation and comparison of two different approaches, GRID/CPCA and GRIND/CPCA (CPCA = consensus principal component analysis… 
2001
2001
The entire pathway for the synthesis of a fluorescent holophycobiliprotein subunit from a photosynthetic cyanobacterium… 
2000
2000
It is known that adenosine decreases blood pressure (BP) level as well as blood pressure variability (BPV). However, there is… 
1995
1995
Strain 4R is a phycocyanin-minus mutant of the unicellular cyanobacterium Synechocystis sp. strain 6803. Although it lacks the… 
Highly Cited
1990
Highly Cited
1990
Human rTNF-alpha (greater than or equal to U/ml) decreased PMN nondirected and directed migration to FMLP to approximately 50% of…